Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1290251.RAOvUnYURI98GR88qkOhOniP6V6nhncSwfuMjglC6ihYw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1290251.RAOvUnYURI98GR88qkOhOniP6V6nhncSwfuMjglC6ihYw130_assertion type Assertion NP1290251.RAOvUnYURI98GR88qkOhOniP6V6nhncSwfuMjglC6ihYw130_head.
- NP1290251.RAOvUnYURI98GR88qkOhOniP6V6nhncSwfuMjglC6ihYw130_assertion description "[The MEK inhibitor trametinib is globally approved for metastatic melanoma harboring BRAF mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1290251.RAOvUnYURI98GR88qkOhOniP6V6nhncSwfuMjglC6ihYw130_provenance.
- NP1290251.RAOvUnYURI98GR88qkOhOniP6V6nhncSwfuMjglC6ihYw130_assertion evidence source_evidence_literature NP1290251.RAOvUnYURI98GR88qkOhOniP6V6nhncSwfuMjglC6ihYw130_provenance.
- NP1290251.RAOvUnYURI98GR88qkOhOniP6V6nhncSwfuMjglC6ihYw130_assertion SIO_000772 26181424 NP1290251.RAOvUnYURI98GR88qkOhOniP6V6nhncSwfuMjglC6ihYw130_provenance.
- NP1290251.RAOvUnYURI98GR88qkOhOniP6V6nhncSwfuMjglC6ihYw130_assertion wasDerivedFrom befree-2016 NP1290251.RAOvUnYURI98GR88qkOhOniP6V6nhncSwfuMjglC6ihYw130_provenance.
- NP1290251.RAOvUnYURI98GR88qkOhOniP6V6nhncSwfuMjglC6ihYw130_assertion wasGeneratedBy ECO_0000203 NP1290251.RAOvUnYURI98GR88qkOhOniP6V6nhncSwfuMjglC6ihYw130_provenance.